Coronavirus Disease 2019 Pandemic, Fibromyalgia
Conditions
Keywords
fibromyalgia, coronavirus disease 2019, pain, anxiety, quality of life
Brief summary
Fibromyalgia patients and controls living in the same household will be evaluated for levels of resilience, covid-19 related anxiety, coronavirus disease 2019 related obsession, quality of life and pain and comparisons and correlation analyses will be carried out.
Detailed description
Fibromyalgia is a generalized pain condition that is accompanied by sleep disturbances, anxiety, depression and somatic symptoms. During Coronavirus disease 2019 pandemic, fibromyalgia patients as well as the general population have increased anxiety levels. This study was planned to evaluate fibromyalgia patients' levels of coronavirus disease 2019 related resilience, anxiety, obsession levels about coronavirus disease 2019, quality of life and pain levels and compare them with healthy controls living in the same household.
Interventions
OTHERQuestionnaires and physical examination
Patients will be examined and demographic data, disease characteristics will be recorded. Health Survey Questionnaire Short Form 36 , coronavirus disease 2019 anxiety scale ,Obsession with coronavirus disease 2019 scale, and Resilience scale for adults will be answered
OTHERQuestionnaire
Demographic data will be recorded. Health Survey Questionnaire Short Form 36 , coronavirus disease 2019 anxiety scale ,Obsession with coronavirus disease 2019 scale, and Resilience scale for adults will be answered
Sponsors
Ege University
Study design
Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Having a diagnosis of fibromyalgia according to the American college of rheumatology 2016 classification criteria * Older than 18 years of age
Exclusion criteria
* Illiteracy * A history of coronavirus disease 2019 infection in the last month * Change in medication to treat fibromyalgia in the last 3 months * Living alone (lack of a control subject) * Severe neurological or psychiatric disorder that might hinder subjects' ability to answer the study questions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Resilience | Day 1 | Immunity against traumatic life events, measured by resilience scale for adults |
| Covid anxiety | Day 1 | Covid related anxiety levels, measured by covid-19 anxiety scale |
| Obsession with covid-19 | Day 1 | Obsession with covid-19, measured by obsession with covid scale |
| Quality of life assessment | Day 1 | Measured by Health Survey Questionnaire Short Form 36 |
Countries
Turkey (Türkiye)
Outcome results
None listed